As of January 22, 2025, Adocia SA (ADOC.PA) has a market cap of $99.690 million USD. According to our data, Adocia SA is ranked No.7693 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $99.69 M |
1.86%
|
Dec 31, 2024 | $97.87 M |
-47.92%
|
Dec 29, 2023 | $0.19 B |
190.68%
|
Dec 30, 2022 | $64.65 M |
-50.99%
|
Dec 31, 2021 | $0.13 B |
-2.41%
|
Dec 31, 2020 | $0.14 B |
-16.16%
|
Dec 31, 2019 | $0.16 B |
-40.15%
|
Dec 31, 2018 | $0.27 B |
15.26%
|
Dec 29, 2017 | $0.23 B |
-76.48%
|
Dec 30, 2016 | $0.99 B |
8,164.46%
|
Dec 30, 2015 | $12.02 M |
-98.47%
|
Dec 31, 2014 | $0.79 B |
709.56%
|
Dec 31, 2013 | $97.06 M |
-39.80%
|
Dec 28, 2012 | $0.16 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Novo Nordisk
NVO
|
$335.24 B |
64.098 B
|
Denmark
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Market Cap | = | ADOC.PA Stock Price | * | ADOC.PA Shares Outstanding |
= | $6.25 | * | 15.64 M | |
= | $99.69 M |